Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

These brain areas are also linked to impulsivity and emotional control in people with ADHD. By reducing food cravings and constant thoughts about eating, GLP⁠-1s may help some people feel more focused ...

“Every single study of weight loss shows that when you just count your calories and eat less, your basal metabolic rate—the ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

Compared with semaglutide and insulin, tirzepatide was associated with improved glycemic control and weight loss outcomes among patients with type 2 diabetes. Tirzepatide is associated with longer ...

The rapid adoption of weight-loss medications such as Ozempic, Wegovy and Zepbound represents one of the most striking cultural shifts in weight management I’ve witnessed in nearly 30 years of ...

Originally developed for Type 2 diabetes, GLP-1 drugs like Ozempic and Wegovy prolong natural satiety signals, extending the ...

Orforglipron shows stronger blood sugar control and greater weight loss than semaglutide tablets, positioning it as a promising oral alternative for patients not responding to metformin ...

Add Yahoo as a preferred source to see more of our stories on Google. Prescriptions for drugs like Wegovy have surged across the board — but rates have climbed especially steeply among young women.

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Menopausal weight gain is common, driven by hormonal changes and decreased muscle mass and energy expenditure. Hormone therapy is weight neutral and should not be used for weight loss; it may help ...

Kenyan celebrities are driving a surge in weight‑loss and cosmetic procedures, sparking criticism and concerns.